Menu
Back to Journals » Drug, Healthcare and Patient Safety » Volume 6
Review
Benefit–risk assessment of new and emerging treatments for hepatitis C: focus on simeprevir and sofosbuvir
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 13,622 | Dovepress* | 10,263+ | 2,548 | 12,811 | |
| PubMed Central* | 3,359 | 1,082 | 4,441 | ||
| Totals | 13,622 | 3,630 | 17,252 | ||
|
*Since 31 March 2014 +Since July 2016 |
|||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 10 | 0 | 0 | 0 | 3 | 7 |
View citations on PubMed Central and Google Scholar